Risk Factors Associated with a Second Primary Lung Cancer in Patients with an Initial Primary Lung Cancer
Amanda Fisher(Wayne State University), Misako Nagasaka(University of California, Irvine), Hirva Mamdani(Wayne State University), Frank A. Baciewicz(Wayne State University), Kimberly Belzer(The Barbara Ann Karmanos Cancer Institute), MaryAnn Milczuk(The Barbara Ann Karmanos Cancer Institute), Courtney E. French(Broad Institute), Seongho Kim(Wayne State University), Antoinette J. Wozniak(Wayne State University), Ann G. Schwartz(The Barbara Ann Karmanos Cancer Institute), Dina Farhat(The Barbara Ann Karmanos Cancer Institute), Ammar Sukari(The Barbara Ann Karmanos Cancer Institute)
Cited by 17
Related Papers
Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals
|Nature|2009|4.2k
Rociletinib in <i>EGFR</i>-Mutated Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2015|664
Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study
|Journal of Clinical Oncology|2017|653
Comparative Functional Genomics of the Fission Yeasts
|Science|2011|528
Immunotherapy in Lung Cancer: Current Landscape and Future Directions
|Frontiers in Immunology|2022|373